ChemBriefPepsiCo Struggles to Meet Targets Amid GLP-1 Threat and Activist Pressure
PepsiCo faces pressure from activist investor Elliott as GLP-1 weight-loss drugs threaten core snack and beverage sales. The company struggles with rising input costs and shrinking volumes ahead of qu
reuters · 2026-10-07 04:12